Page results
-
UCLH’s trial of the world’s first ‘gene silencing’ drug for Alzheimer’s disease has progressed into a larger and later stage trial, after promising early results.
-
Men currently attending a hospital outpatient clinic for prostate hormone injections every 3 or 6 months will be advised that (unless not clinically appropriate) their next injection will be administered at a local GP practice, usually by the practice nurse.
-
All semen analysis referrals should be made via the NHS e-Referral Service (e-RS). We will no longer be able to book semen analysis appointments through direct requests from patients or GP surgeries via email.
-
We are now administering new COVID-19 treatments for patients at highest risk in the community. The service can prescribe oral antivirals to be taken at home, and give intravenous antibody treatments at the hospital.
-
How we use your information at UCLH: what you need to know
-
This page is for patients who are about to start a course of radiotherapy to the pelvis for a gynaecological cancer.
-
A UCLH investment of £20 million will fund training for healthcare assistants and major new research facilities which will benefit patient care.
-
Information for new neuro-otology patients
-
People with obesity whose weight and health improve following drug treatment are likely to need the treatment long term, according to a UCLH and UCL study.
-
UCLH Director of Research Professor Bryan Williams has been elected as the next President of the International Society of Hypertension (ISH).
File results
-
FOI/2023/0437 - Outsourced and insourced procedures for dermatology, endoscopy and gynaecology procedures from 2017/18-2022/23
-
FOI/2023/0438 - Outsourced and insourced procedures dermatology, endoscopy and gynaecological procedures
-
FOI/2023/0443 - Food provision at Trust for staff and patients
-
FOI/2023/0444 - Emergency scrotal explorations (surgical procedure) for June 2022-May 2023
-
FOI/2023/0445 - Number of people (patients, staff, members of public) stabbed from 2018-2022
-
FOI/2023/0448 - Gender, transgender, non-binary guidance/ policy for staff and patients
-
FOI/2023/0449 - Endometriosis pathway
-
FOI/2023/0450 - Pain relief options (remifentanil, entonox and sterile water injections) during labour
-
Neuroimmunology and CSF Laboratory User Handbook
-
NIHR Patient Research Experience Survey 2022-2023